Site of Infection Associated With Increased Risk for PsA and Psoriasis
Researchers evaluated the association between pharyngeal infections and incident psoriatic arthritis and psoriasis.
Psoriatic Arthritis
High Erythrocyte Mean Corpuscular Volume Predicts Methotrexate Response in PsA
Researchers investigated the generalizability of a previous study finding that increased mean corpuscular volume complements clinical response in psoriatic arthritis.
Candidate Biomarkers Identified for Psoriasis Progression
Candidate biomarkers for disease progression in psoriasis have been identified, according to a review published online.
![There are no uniform guidelines regarding DMARD tapering. EULAR guidelines suggest RA pharmacotherapy should be de-escalated in the following order: glucocorticoids, biologic DMARDs, and, finally, conventional DMARDs, with each treatment stopping completely before de-escalation of the next agent in the sequence.[4] Numerous DMARD dose-tapering protocols have been studied, including immediate discontinuation of treatment. When the goal is to withdraw treatment, the ACR recommends an initial dose-tapering phase to enable better monitoring of patient response and candidacy for discontinuation.[5] The ACR also strongly encourages patient involvement in decisions regarding their individual DMARD tapering protocol.](https://www.dermatologyadvisor.com/wp-content/uploads/sites/20/2022/04/syringedrugsts53728911801_1026507-544x306.jpg)
Comparing the Efficacy, Safety of Systemic Therapies in the Treatment of PsA Manifestations
Authors of a systematic review compared the efficacy and safety of systemic therapies in the treatment of manifestations of active psoriatic arthritis.
Treatment Refractory and Super-Responders in Psoriasis Biologic Agent Treatment
Researchers sought to recognize and describe the patients with psoriasis at both ends of the biologic agent treatment spectrum.
Risk for Severe COVID-19 Low in Patients With Psoriatic Disease
Researchers reported on the severity of COVID-19 outcomes in patients with psoriatic disease, using data from the WARCOV study.
Psoriasis Severity in HIV Associated With Low CD4 T-Cell Count
The characteristics of a general psoriasis populations were compared with that of those patients with psoriasis living with HIV.
IL-17 vs TNF Inhibitors for New Biologic Agent Users With Psoriatic Disease
The long-term persistence of various biologic agents in treating psoriasis and psoriatic arthritis are investigated.
Novel Predictive Model Evaluates Risk for Psoriatic Arthritis in Patients With Plaque Psoriasis
Researchers developed a novel prediction model to evaluate the risk for psoriatic arthritis in plaque psoriasis, using available patient characteristics and clinical manifestations.
How Much Does Pain Catastrophizing Affect Patients With RA, PsA, and axSpA?
Researchers analyzed pain catastrophizing in patients with rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis from a biopsychosocial perspective.
- Loading...
Loading...
Next post in Psoriasis
Loading... 
Loading...